The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 02, 2021

Filed:

Nov. 30, 2017
Applicant:

International Business Machines Corporation, Armonk, NY (US);

Inventors:

Meenakshi Nagarajan, San Jose, CA (US);

Alix Lacoste, Brooklyn, NY (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G16B 40/00 (2019.01); G06F 16/33 (2019.01); G16H 10/20 (2018.01); G16B 20/00 (2019.01); G16H 20/10 (2018.01); G16H 70/40 (2018.01); G16B 5/00 (2019.01); G16B 25/10 (2019.01); G16B 35/20 (2019.01); G01N 33/50 (2006.01); C12Q 1/02 (2006.01); G01N 21/64 (2006.01); G16B 50/00 (2019.01);
U.S. Cl.
CPC ...
G16B 40/00 (2019.02); C12Q 1/025 (2013.01); G01N 33/5023 (2013.01); G06F 16/334 (2019.01); G16B 5/00 (2019.02); G16B 20/00 (2019.02); G16B 25/10 (2019.02); G16B 35/20 (2019.02); G16H 10/20 (2018.01); G16H 20/10 (2018.01); G16H 70/40 (2018.01); G01N 21/6486 (2013.01); G06F 2216/03 (2013.01); G16B 50/00 (2019.02);
Abstract

Utilizing a computing device to assist in repurposing of a pharmaceutical. An identification of a pharmaceutical for repurposing study is received by a computing device. A pharmaceutical expression signature is retrieved based upon the identification of the pharmaceutical, the pharmaceutical expression signature indicating differential expressions of a plurality of biomolecules regulated by the pharmaceutical. A plurality of disease expression signatures are retrieved from a disease omics database, each disease expression signature indicating differential expressions of a plurality of biomolecules affected by a disease. A pharmaceutical vector is generated based upon the pharmaceutical expression signature for the pharmaceutical. A plurality of disease vectors are generated based upon the plurality of disease expression signatures for each disease. N hypotheses correlating the pharmaceutical vector and one or more of the plurality of disease vectors are generated, each hypothesis indicating a potential repurposing for the pharmaceutical to treat the disease.


Find Patent Forward Citations

Loading…